Menu

Blog

Aug 17, 2023

Cervavac, India’s own HPV vaccine for cervical cancer, is now in pvt hospitals: Who should get it first? What’s its efficacy?

Posted by in category: biotech/medical

Plans are already under way to roll it out for the public sector too by the end of the year. With a 2–3 million dose production capacity, a single dose of the two-dose vial is priced at Rs 2,000 currently. Vaccine effective against high risk types of the cancer-causing virus, say oncologists.

Comments are closed.